Dr Reddy's Labs Q4 Results : Cons PAT jumps 22% to Rs 1,594 crore ; Rs 8 per share dividend (...)
Dr Reddy's Labs Q4 Results: Dr Reddy's Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period.
Site référencé: The Economic Times
The Economic Times
UltraTech Cement Q4 Preview : Volume growth to support earnings ; margins seen steady
27/04/2025
FPIs extend investment in Indian equities, inject Rs 17,425 cr in a week
27/04/2025
How to calculate the market cap to sales ratio and what it means
27/04/2025
These 7 penny stocks rally 25-75% in a week
27/04/2025
